BMO Starts coverage on Merck with a “Market Perform” Rating (MRK)

By
A A A
Share |

Pharmaceuticals giant Merck & Co., Inc. ( MRK ) on Friday caught some lukewarm commentary from analysts at BMO Capital.

The firm initiated coverage on MRK with a "Market Perform" rating and a $43 price target, which suggests a 13% upside to the stock's Thursday closing price. BMO Capital said the rating was a valuation call based on that price target.

Merck shares, which have risen about 1% year-to-date, were mostly flat in premarket trading Friday.


The Bottom Line
Shares of Merck ( MRK ) have a 4.42% dividend yield, based on last night's closing stock price of $38.03. The stock has technical support in the $36 price area. If the shares can firm up, we see overhead resistance around the $39-$40 price levels.

Merck & Co., Inc. ( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: MRK

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

82%

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com